F00 F01 F02 F03
Conditions
Interventions
Group 1: care by specifically trained general practitioners
use of an outpatient clinic, case management or regional support options (depending on the respective needs of the patients)
Group 2: care by partly trained general practitioners, contact with case ma
Sponsors
Universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: diagnosis of dementia, place of residence within the study area, informed consent to participate in DemStepCare
Exclusion criteria
Exclusion criteria: living in a nursing home
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| days of inpatient treatment (intervention group vs. control group 1): self-developed questionnaire item patients' quality of life: Quality of Life in Alzheimer's Disease (QOL-AD) caregivers' burden of care: Berlin Inventory of Caregivers‘ Burden with Dementia Patients (BIZA-D) The primary end points are measured at study inclusion and after 9 months (11 months for patients who have undergone a Covid-19 related treatment break). | — |
Secondary
| Measure | Time frame |
|---|---|
| caregivers' quality of life and comorbidities: World Health Organization Quality of Life Short Form (WHOQOL-Bref), comorbidity score (KoMo-Score) caregivers' stress: 10-point scale, Perceived Stress Scale (PSS-10) caregivers' resilience: Brief Resilience Scale (BRS) stability of care situation: Dementia specific screening tool (DSV) days of inpatient treatment (intervention group vs. control group 2): self-developed questionnaire item and data from health insurance companies hospital admissions: self-developed questionnaire item and data from health insurance companies use of regional support services: self-developed items adequacy of medication: Medication Appropriateness Index (MAI) general practitioners' dementia sensitivity: panel survey, self-developed items The secondary end points relating to patients and caregivers are measured at study inclusion and after 9 months (11 months for patients who have undergone a Covid-19 related treatment break). There are also longitudinal analyses in the intervention group covering the entire duration of the intervention. The secondary end points relating to the general practitioners are measured at baseline (i.e. before the first training sessions), 12 months after completion of the first training, and at the end of the intervention phase. | — |
Countries
Germany
Contacts
Public ContactTeresa Weber
Zentrum für psychische Gesundheit im Alter (ZpGA) Landeskrankenhaus (AöR)
Outcome results
None listed